Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study.

de Rougemont, Olivier; Deng, Yun; Frischknecht, Lukas; Wehmeier, Caroline; Villard, Jean; Ferrari-Lacraz, Sylvie; Golshayan, Déla; Gannagé, Monique; Binet, Isabelle; Wirthmüller, Urs; Sidler, Daniel; Schachtner, Thomas; Schaub, Stefan; Nilsson, Jakob (2023). Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study. Frontiers in immunology, 14(1104371), p. 1104371. Frontiers Research Foundation 10.3389/fimmu.2023.1104371

Preview

Text fimmu-14-1104371.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (5MB) | Preview

INTRODUCTION

The type of donation may affect how susceptible a donor kidney is to injury from pre-existing alloimmunity. Many centers are, therefore, reluctant to perform donor specific antibody (DSA) positive transplantations in the setting of donation after circulatory death (DCD). There are, however, no large studies comparing the impact of pre-transplant DSA stratified on donation type in a cohort with a complete virtual cross-match and long-term follow-up of transplant outcome.

METHODS

We investigated the effect of pre-transplant DSA on the risk of rejection, graft loss, and the rate of eGFR decline in 1282 donation after brain death (DBD) transplants and compared it to 130 (DCD) and 803 living donor (LD) transplants.

RESULTS

There was a significant worse outcome associated with pre-transplant DSA in all of the studied donation types. DSA directed against Class II HLA antigens as well as a high cumulative mean fluorescent intensity (MFI) of the detected DSA showed the strongest association with worse transplant outcome. We could not detect a significant additive negative effect of DSA in DCD transplantations in our cohort. Conversely, DSA positive DCD transplants appeared to have a slightly better outcome, possibly in part due to the lower mean fluorescent intensity (MFI) of the pre-transplant DSA. Indeed when DCD transplants were compared to DBD transplants with similar MFI (<6.5k), graft survival was not significantly different.

DISCUSSION

Our results suggest that the negative impact of pre-transplant DSA on graft outcome could be similar between all donation types. This suggests that immunological risk assessment could be performed in a similar way regardless of the type of donor kidney transplantation.

Interest & Impact

Downloads

74 since deposited on 07 Mar 2023
15 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item